Ftse Mib
34.375,92
-0,59%
DAX
18.590,89
-0,95%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
64.624,71
-0,35%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
05/10/202214:00Business WireAbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022NASDAQ:ABCLAbCellera Biologics Inc
26/09/202215:50TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), AbCellera Biologics (ABCL)NASDAQ:ABCLAbCellera Biologics Inc
21/09/202214:00Business WireAbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the ClinicNASDAQ:ABCLAbCellera Biologics Inc
22/08/202221:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
11/08/202205:16TipRanksSVB Securities Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)NASDAQ:ABCLAbCellera Biologics Inc
10/08/202215:35TipRanksBMO Capital Remains a Buy on AbCellera Biologics (ABCL)NASDAQ:ABCLAbCellera Biologics Inc
10/08/202212:06TipRanksAbCellera Biologics (ABCL) Receives a Buy from Berenberg BankNASDAQ:ABCLAbCellera Biologics Inc
09/08/202222:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
09/08/202222:05Business WireAbCellera Reports Q2 2022 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
03/08/202218:05TipRanksBerenberg Bank Sticks to Its Buy Rating for AbCellera Biologics (ABCL)NASDAQ:ABCLAbCellera Biologics Inc
03/08/202213:00Business WireAbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for PatientsNASDAQ:ABCLAbCellera Biologics Inc
27/07/202213:00Business WireVersant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech CompaniesNASDAQ:ABCLAbCellera Biologics Inc
22/07/202222:39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ABCLAbCellera Biologics Inc
12/07/202222:05Business WireAbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022NASDAQ:ABCLAbCellera Biologics Inc
04/07/202204:47TipRanksSVB Securities Sticks to Its Buy Rating for AbCellera Biologics (ABCL)NASDAQ:ABCLAbCellera Biologics Inc
29/06/202217:04Business WireLilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment OptionsNASDAQ:ABCLAbCellera Biologics Inc
11/05/202214:49TipRanksAbCellera Biologics (ABCL) Receives a Buy from SVB SecuritiesNASDAQ:ABCLAbCellera Biologics Inc
11/05/202214:49TipRanksBMO Capital Thinks AbCellera Biologics’ Stock is Going to RecoverNASDAQ:ABCLAbCellera Biologics Inc
11/05/202212:30TipRanksBerenberg Bank Thinks AbCellera Biologics’ Stock is Going to RecoverNASDAQ:ABCLAbCellera Biologics Inc
10/05/202222:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABCLAbCellera Biologics Inc
10/05/202222:05Business WireAbCellera Reports Q1 2022 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
03/05/202215:00Business WireAbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery CollaborationNASDAQ:ABCLAbCellera Biologics Inc
28/04/202220:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABCLAbCellera Biologics Inc
28/04/202220:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ABCLAbCellera Biologics Inc
26/04/202222:05Business WireAbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022NASDAQ:ABCLAbCellera Biologics Inc
12/04/202222:05Business WireAbCellera to Report First Quarter 2022 Financial Results on May 10, 2022NASDAQ:ABCLAbCellera Biologics Inc
08/04/202219:05Business WireAbCellera Presents Data on T Cell Engager Platform at AACR 2022NASDAQ:ABCLAbCellera Biologics Inc
25/02/202221:51Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ABCLAbCellera Biologics Inc
25/02/202220:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABCLAbCellera Biologics Inc
24/02/202222:05Business WireAbCellera Reports Full Year 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

BIT
P22B64
NLBNPIT22B64 20240717 4900
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network